Search Results for: Dr Tom Williams

In Canada, Quebec is abolishing the rule introduced in 1994 to authorise reimbursement for 15 years for innovative drugs supplied through the province’s public prescription drug insurance plan, even after their patents had expired and if cheaper alternatives, including generics, were available.

Biogen Idec has been boosted by the news that it has received conditional approval from the European Commission for Fampyra, which improves walking in patients with multiple sclerosis.

New guidance from the National Institute for Health and Care Excellence (NICE) says that around 7,000 strokes and 2,000 premature deaths could be prevented each year through effective detection of atrial fibrillation (AF) and protection with anticoagulant drugs.